Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1987 Nov 1;166(5):1499–1509. doi: 10.1084/jem.166.5.1499

Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized

PMCID: PMC2189655  PMID: 3316472

Abstract

Lethally irradiated C.B-17 +/+, C.B-17 scid/scid (severe combined immunodeficiency, SCID), BALB/c-nu/nu (nude), and C57BL/6 (B6) mice were challenged with H-2-homozygous or H-2-heterozygous totally allogeneic bone marrow cell (BMC) grafts. Some of the irradiated mice were immunized simultaneously with large numbers of irradiated marrow and spleen cells syngeneic with the viable BMC transferred. Irradiated SCID and nude mice, devoid of T cells but with normal NK cell function, were able to reject H-2-homozygous BMC grafts within 4 d. However, they were unable to reject H-2-heterozygous BMC allografts by 7 d even if they were immunized. B6 and C.B-17 +/+ mice were able to reject H-2 heterozygous BMC allografts by 7-8 d, but not as early as 4 d, if they were immunized. The rejection of H-2-homozygous BMC on day 4 was inhibited by administration of anti-NK-1.1 antibodies, but not by anti- Lyt-2 antibodies. Conversely, the rejection of H-2-heterozygous allogeneic BMC on day 8 was prevented by anti-Lyt-2 but not by anti-NK- 1.1 antibodies. The data indicate that both NK cells and Lyt-2+ T cells can mediate rejection of allogeneic BMC acutely, even after exposure of mice to lethal doses of ionizing irradiation. NK cells appear to recognize Hemopoietic histocompatibility (Hh) antigens on H-2 homozygous stem cells. The inability of SCID and nude mice to reject H- 2 heterozygous totally allogeneic BMC indicate that NK cells do not survey donor marrow cells for self H-2 antigens and reject those cells that express nonself H-2 antigens. The T cells presumably recognize conventional H-2 antigens (probably class I) under these conditions.

Full Text

The Full Text of this article is available as a PDF (694.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aizawa S., Sado T., Kamisaku H., Kubo E. Cellular basis of the immunohematologic defects observed in short-term semiallogeneic B6C3F1 -- C3H chimeras: evidence for host-versus-graft reaction initiated by radioresistant T cells. Cell Immunol. 1980 Nov;56(1):47–57. doi: 10.1016/0008-8749(80)90080-5. [DOI] [PubMed] [Google Scholar]
  2. Bennett M., Cudkowicz G., Foster R. S., Jr, Metcalf D. Hemopoietic progenitor cells of W anemic mice studies in vivo and in vitro. J Cell Physiol. 1968 Jun;71(3):211–226. doi: 10.1002/jcp.1040710304. [DOI] [PubMed] [Google Scholar]
  3. Bennett M. Rejection of marrow allografts: importance of H-2 homozygosity of donor cells. Transplantation. 1972 Sep;14(3):289–298. doi: 10.1097/00007890-197209000-00001. [DOI] [PubMed] [Google Scholar]
  4. Cudkowicz G., Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med. 1971 Jul 1;134(1):83–102. doi: 10.1084/jem.134.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cudkowicz G., Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J Exp Med. 1971 Dec 1;134(6):1513–1528. doi: 10.1084/jem.134.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dennert G., Anderson C. G., Warner J. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance. J Immunol. 1985 Dec;135(6):3729–3734. [PubMed] [Google Scholar]
  7. Doherty P. C., Knowles B. B., Wettstein P. J. Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. Adv Cancer Res. 1984;42:1–65. doi: 10.1016/s0065-230x(08)60455-8. [DOI] [PubMed] [Google Scholar]
  8. Dorshkind K., Pollack S. B., Bosma M. J., Phillips R. A. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol. 1985 Jun;134(6):3798–3801. [PubMed] [Google Scholar]
  9. Gassmann W., Wottge H. U., von Kolzynski M., Müller-Ruchholtz W. Immune reactivity after high-dose irradiation. Transplantation. 1986 Mar;41(3):380–384. doi: 10.1097/00007890-198603000-00019. [DOI] [PubMed] [Google Scholar]
  10. Gidlund M., Orn A., Pattengale P. K., Jansson M., Wigzell H., Nilsson K. Natural killer cells kill tumour cells at a given stage of differentiation. Nature. 1981 Aug 27;292(5826):848–850. doi: 10.1038/292848a0. [DOI] [PubMed] [Google Scholar]
  11. Kiessling R., Hochman P. S., Haller O., Shearer G. M., Wigzell H., Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol. 1977 Sep;7(9):655–663. doi: 10.1002/eji.1830070915. [DOI] [PubMed] [Google Scholar]
  12. Koo G. C., Dumont F. J., Tutt M., Hackett J., Jr, Kumar V. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol. 1986 Dec 15;137(12):3742–3747. [PubMed] [Google Scholar]
  13. Kärre K., Ljunggren H. G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986 Feb 20;319(6055):675–678. doi: 10.1038/319675a0. [DOI] [PubMed] [Google Scholar]
  14. Lengerová A., Matousek V., Zelený V. Analysis of deficient colony-forming performance of bone marrow cells in non-syngeneic cell milieu--the impact of non-immune interactions on the behaviour of pluripotent stem cells and the role of H-2 gene products. Transplant Rev. 1973;15:89–122. doi: 10.1111/j.1600-065x.1973.tb00112.x. [DOI] [PubMed] [Google Scholar]
  15. Ljunggren H. G., Kärre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med. 1985 Dec 1;162(6):1745–1759. doi: 10.1084/jem.162.6.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Murphy W. J., Kumar V., Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med. 1987 Apr 1;165(4):1212–1217. doi: 10.1084/jem.165.4.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rembecki R. M., Bennett M., Kumar V., Potter T. A. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation. J Immunol. 1987 Apr 15;138(8):2734–2738. [PubMed] [Google Scholar]
  18. Schuler W., Weiler I. J., Schuler A., Phillips R. A., Rosenberg N., Mak T. W., Kearney J. F., Perry R. P., Bosma M. J. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell. 1986 Sep 26;46(7):963–972. doi: 10.1016/0092-8674(86)90695-1. [DOI] [PubMed] [Google Scholar]
  19. Warner J. F., Dennert G. Bone marrow graft rejection as a function of antibody-directed natural killer cells. J Exp Med. 1985 Mar 1;161(3):563–576. doi: 10.1084/jem.161.3.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. von Melchner H., Bartlett P. F. Mechanisms of early allogeneic marrow graft rejection. Immunol Rev. 1983;71:31–56. doi: 10.1111/j.1600-065x.1983.tb01067.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES